Search results
v. t. e. The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).
Apr 30, 2024 · How It Works. The Moderna vaccine is an mRNA vaccine, similar to the one developed by Pfizer. The technology behind these vaccines has been around for about three decades and shown promise in preventing notoriously difficult-to-prevent diseases—even cancer.
Aug 18, 2022 · For adults aged 17 and above, SAGE recommends the use of the Moderna mRNA-1273 vaccine at a schedule of two doses (100 µg, 0.5 ml each) 8 weeks apart. For adolescents aged 12 to 17 years, SAGE recommends 2 doses (100 µg, 0.5 ml each), given intramuscularly, 4 weeks apart.
Nov 1, 2023 · Information about Moderna COVID-19 Vaccine, Bivalent. Updated, bivalent mRNA COVID-19 vaccines are now FDA-authorized for all doses for individuals ages 6 months and older.
May 13, 2021 · How does Moderna’s vaccine work? Moderna’s vaccine against the original strain is given as two doses. Both this vaccine, and the updated booster, are mRNA vaccines (like the Pfizer vaccine). The...
PUTRAJAYA: The mRNA-based vaccine from ModernaTX Inc is the latest to join Malaysia’s line-up of Covid-19 jabs after it received the Health Ministry’s approval for emergency use.
Moderna, a Massachusetts-based vaccine developer, partnered with the National Institutes of Health to develop and test a coronavirus vaccine known as mRNA-1273. A clinical trial demonstrated...
This Vaccine Information Fact Sheet for Recipients and Caregivers comprises the Fact Sheet for the authorized Moderna COVID-19 Vaccine and also includes information about the FDA-licensed...
Apr 30, 2021 · Today, WHO listed the Moderna COVID-19 vaccine (mRNA 1273) for emergency use, making it the fifth vaccine to receive emergency validation from WHO. WHO’s Emergency Use Listing (EUL) assesses the quality, safety and efficacy of COVID-19 vaccines and is a prerequisite for COVAX Facility vaccine supply.
Mar 26, 2024 · The NEXTCove clinical trial is a randomized, observer-blind, active-controlled study of approximately 11,400 individuals aged 12 years and older in the United States, United Kingdom and Canada. mRNA-1283 was found to have a similar safety profile to Moderna's approved COVID-19 vaccines.
